Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review

JM Liberto, SY Chen, IM Shih, TH Wang, TL Wang… - Cancers, 2022 - mdpi.com
Simple Summary Ovarian high-grade serous carcinoma (HGSC) has a 5-year survival rate
of less than 50%, making it one of the most lethal gynecological cancers for women in the …

Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies

J Kaijser, T Bourne, L Valentin… - … in obstetrics & …, 2013 - Wiley Online Library
In order to ensure that ovarian cancer patients access appropriate treatment to improve the
outcome of this disease, accurate characterization before any surgery on ovarian pathology …

Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group

D Timmerman, B Van Calster, A Testa, L Savelli… - American journal of …, 2016 - Elsevier
Background Accurate methods to preoperatively characterize adnexal tumors are pivotal for
optimal patient management. A recent metaanalysis concluded that the International …

Multi-biomarker panel signature as the key to diagnosis of ovarian cancer

T Muinao, HPD Boruah, M Pal - Heliyon, 2019 - cell.com
Early detection of ovarian cancer has been a challenge to manage the high mortality rate
caused by this deadly disease. The trends in mortality have been reduced by the scientific …

The role of biomarkers in the management of epithelial ovarian cancer

WL Yang, Z Lu, RC Bast Jr - Expert review of molecular diagnostics, 2017 - Taylor & Francis
Introduction: Despite advances in surgery and chemotherapy for ovarian cancer, 70% of
women still succumb to the disease. Biomarkers have contributed to the management of …

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer

CWS Kan, MA Hahn, GB Gard, J Maidens, JY Huh… - BMC cancer, 2012 - Springer
Background There is a critical need for improved diagnostic markers for high grade serous
epithelial ovarian cancer (SEOC). MicroRNAs are stable in the circulation and may have …

High-throughput approaches for precision medicine in high-grade serous ovarian cancer

M Govindarajan, C Wohlmuth, M Waas… - Journal of hematology & …, 2020 - Springer
High-grade serous carcinoma (HGSC) is the most prevalent and aggressive subtype of
ovarian cancer. The large degree of clinical heterogeneity within HGSC has justified …

MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer

Y Gao, J Wu - Tumor Biology, 2015 - Springer
Ovarian cancer is the fifth leading cause of female death globally due to its low survival
rates. Thus, improved approaches for ovarian cancer detection are urgently needed …

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography

EJ Pavlik, FR Ueland, RW Miller… - Obstetrics & …, 2013 - journals.lww.com
OBJECTIVE: To examine the prevalence, incidence, persistence, and resolution of ovarian
abnormalities using serial transvaginal ultrasonography. METHODS: A group of 39,337 …

[HTML][HTML] Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective

M Montagnana, M Benati, E Danese - Annals of translational …, 2017 - ncbi.nlm.nih.gov
Ovarian cancer (OC) represents the most lethal gynecological cancer and the poor
prognosis is often attributable to late diagnosis. The diagnostic approach to woman …